help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0395
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solanes, G.
Right arrow Articles by Villarroya, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solanes, G.
Right arrow Articles by Villarroya, F.
Molecular Endocrinology 17 (10): 1944-1958
Copyright © 2003 by The Endocrine Society

Functional Relationship between MyoD and Peroxisome Proliferator-Activated Receptor-Dependent Regulatory Pathways in the Control of the Human Uncoupling Protein-3 Gene Transcription

Gemma Solanes, Neus Pedraza, Roser Iglesias, Marta Giralt and Francesc Villarroya

Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona, E-08028 Barcelona, Spain

Address all correspondence and requests for reprints to: Francesc Villarroya, Department de Bioquímica i Biologia Molecular, Universitat de Barcelona, Avda Diagonal 645, E-08028-Barcelona, Spain. E-mail: gombau{at}porthos.bio.ub.es.

Uncoupling protein-3 (UCP3) gene is a member of the mitochondrial carrier superfamily preferentially expressed in skeletal muscle and up-regulated by fatty acids. Peroxisome proliferator-activated receptor (PPAR){alpha} and PPAR{delta} (also known as PPARß) mediate human UCP3 gene regulation by fatty acids through a direct-repeat (DR-1) element in the promoter. DR-1 mutation renders UCP3 promoter unresponsive to PPAR ligand in vitro and consistently blocks gene induction by fatty acids in vivo. Although they act through separate sites in the promoter, MyoD and PPAR-dependent regulatory pathways are functionally connected: only in the presence of MyoD, does UCP3 become sensitive to PPAR ligand-dependent regulation. MyoD controls UCP3 promoter activity through a noncanonical Ebox site located in the proximal region, close to transcription initiation site. Moreover, acetylation processes play a crucial role in the control of UCP3 gene regulation. The coactivator p300 protein enhances PPAR ligand-mediated regulation whereas a mutant form devoid of histone acetylase activity blocks the response of the promoter to fatty acids. Conversely, histone deacetylase-1 blunts MyoD-dependent expression of the UCP3 promoter and reduces PPAR-dependent responsiveness. A mutated form of MyoD unable to be acetylated has a lower transactivation capacity on the human UCP3 promoter with respect to wild-type MyoD. It is concluded that MyoD and PPAR-dependent pathways mediate human UCP3 gene regulation and that acetylase activity elicited by coregulators is implicated in the functional interaction between these regulatory pathways. Therefore the convergence of MyoD and PPAR-dependent pathways provides a molecular mechanism for skeletal muscle specificity and fatty acid regulation of human UCP3 gene.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARα  |  PPARδ  |  PPARγ
Coregulators:   p300  |  HDAC1
Ligands:   Pirinixic acid  |  Rosiglitazone



This article has been cited by other articles:


Home page
EndocrinologyHome page
A. W. Norris, M. F. Hirshman, J. Yao, N. Jessen, N. Musi, L. Chen, W. I. Sivitz, L. J. Goodyear, and C. R. Kahn
Endogenous Peroxisome Proliferator-Activated Receptor-{gamma} Augments Fatty Acid Uptake in Oxidative Muscle
Endocrinology, November 1, 2008; 149(11): 5374 - 5383.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Seifert, V. Bezaire, C. Estey, and M.-E. Harper
Essential Role for Uncoupling Protein-3 in Mitochondrial Adaptation to Fasting but Not in Fatty Acid Oxidation or Fatty Acid Anion Export
J. Biol. Chem., September 12, 2008; 283(37): 25124 - 25131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Lu and M. N. Sack
ATF-1 Is a Hypoxia-responsive Transcriptional Activator of Skeletal Muscle Mitochondrial-uncoupling Protein 3
J. Biol. Chem., August 22, 2008; 283(34): 23410 - 23418.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
B. Rey, B. Sibille, C. Romestaing, M. Belouze, D. Letexier, S. Servais, H. Barre, C. Duchamp, and Y. Voituron
Reptilian uncoupling protein: functionality and expression in sub-zero temperatures
J. Exp. Biol., May 1, 2008; 211(9): 1456 - 1462.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Di Padova, G. Caretti, P. Zhao, E. P. Hoffman, and V. Sartorelli
MyoD Acetylation Influences Temporal Patterns of Skeletal Muscle Gene Expression
J. Biol. Chem., December 28, 2007; 282(52): 37650 - 37659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Amat, G. Solanes, M. Giralt, and F. Villarroya
SIRT1 Is Involved in Glucocorticoid-mediated Control of Uncoupling Protein-3 Gene Transcription
J. Biol. Chem., November 23, 2007; 282(47): 34066 - 34076.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Tsuchiya, H. Sakai, N. Suzuki, F. Iwashima, T. Yoshimoto, M. Shichiri, and Y. Hirata
Chronic Blockade of Nitric Oxide Synthesis Reduces Adiposity and Improves Insulin Resistance in High Fat-Induced Obese Mice
Endocrinology, October 1, 2007; 148(10): 4548 - 4556.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. J. McCarthy, J. L. Andrews, E. L. McDearmon, K. S. Campbell, B. K. Barber, B. H. Miller, J. R. Walker, J. B. Hogenesch, J. S. Takahashi, and K. A. Esser
Identification of the circadian transcriptome in adult mouse skeletal muscle
Physiol Genomics, September 11, 2007; 31(1): 86 - 95.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. de Lange, A. Feola, M. Ragni, R. Senese, M. Moreno, A. Lombardi, E. Silvestri, R. Amat, F. Villarroya, F. Goglia, et al.
Differential 3,5,3'-Triiodothyronine-Mediated Regulation of Uncoupling Protein 3 Transcription: Role of Fatty Acids
Endocrinology, August 1, 2007; 148(8): 4064 - 4072.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Pedraza, M. Rosell, J. Villarroya, R. Iglesias, F. J. Gonzalez, G. Solanes, and F. Villarroya
Developmental and Tissue-Specific Involvement of Peroxisome Proliferator-Activated Receptor-{alpha} in the Control of Mouse Uncoupling Protein-3 Gene Expression
Endocrinology, October 1, 2006; 147(10): 4695 - 4704.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Schrauwen, M. Mensink, G. Schaart, E. Moonen-Kornips, J.-P. Sels, E. E. Blaak, A. P. Russell, and M. K. C. Hesselink
Reduced Skeletal Muscle Uncoupling Protein-3 Content in Prediabetic Subjects and Type 2 Diabetic Patients: Restoration by Rosiglitazone Treatment
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1520 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Baldan, J. Relat, P. F. Marrero, and D. Haro
Functional interaction between peroxisome proliferator-activated receptors-{alpha} and Mef-2C on human carnitine palmitoyltransferase 1{beta} (CPT1{beta}) gene activation
Nucleic Acids Res., September 8, 2004; 32(16): 4742 - 4749.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society